Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPBAR1 | Q8TDU6 | 13/20 | 0.83 |
| ▸ | NR1H4 | Q96RI1 | 5/20 | 0.83 |
| ▸ | MEN1 | O00255 | 2/20 | 0.76 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.76 |
| ▸ | ABCB11 | O95342 | 2/20 | 0.76 |
| ▸ | SLC10A2 | Q12908 | 2/20 | 0.76 |
| ▸ | LMNA | P02545 | 1/20 | 0.76 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.76 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.76 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.76 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.76 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.76 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.76 |
| ▸ | SLC10A1 | Q14973 | 1/20 | 0.76 |
| ▸ | CISD1 | Q9NZ45 | 1/20 | 0.76 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.76 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22278854 | 1.00 | GPBAR1 (0.83) | GPBAR1NR1H4MEN1KMT2AABCB11 | |
| SCHEMBL13220691 | 1.00 | GPBAR1 (0.83) | GPBAR1NR1H4MEN1KMT2AABCB11 | |
| SCHEMBL22317800 | 1.00 | GPBAR1 (0.83) | GPBAR1NR1H4MEN1KMT2AABCB11 | |
| SCHEMBL17191624 | 1.00 | GPBAR1 (0.83) | GPBAR1NR1H4MEN1KMT2AABCB11 | |
| SCHEMBL16917072 | 1.00 | GPBAR1 (0.83) | GPBAR1NR1H4MEN1KMT2AABCB11 | |
| SCHEMBL23748470 | 0.93 | GPBAR1 (0.83) | GPBAR1NR1H4MEN1KMT2AABCB11 | |
| SCHEMBL18071923 | 0.93 | GPBAR1 (0.83) | GPBAR1NR1H4MEN1KMT2AABCB11 | |
| SCHEMBL19866259 | 0.93 | GPBAR1 (0.83) | GPBAR1NR1H4MEN1KMT2AABCB11 | |
| SCHEMBL23748467 | 0.93 | GPBAR1 (0.83) | GPBAR1NR1H4MEN1KMT2AABCB11 | |
| SCHEMBL15292877 | 0.93 | GPBAR1 (0.83) | GPBAR1NR1H4MEN1KMT2AABCB11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200239513-A1 | LONG-ACTING PRODRUGS OF ENTECAVIR, PREPARING METHODS AND USES THEREOF | GUANGZHOU HENOVCOM BIOSCIENCE CO. LTD (CN) | 2020-07-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200239513-A1 | LONG-ACTING PRODRUGS OF ENTECAVIR, PREPARING METHODS AND USES THEREOF | ENTPD5, ENTPD1, TYMP | GPBAR1 1278/4885NR1H4 1408/4885MEN1 2820/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.